205 related articles for article (PubMed ID: 34611744)
1. Human cytomegalovirus multiple-strain infections and viral population diversity in haematopoietic stem cell transplant recipients analysed by high-throughput sequencing.
Dhingra A; Götting J; Varanasi PR; Steinbrueck L; Camiolo S; Zischke J; Heim A; Schulz TF; Weissinger EM; Kay-Fedorov PC; Davison AJ; Suárez NM; Ganzenmueller T
Med Microbiol Immunol; 2021 Dec; 210(5-6):291-304. PubMed ID: 34611744
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Human Cytomegalovirus Genome Diversity in Immunocompromised Hosts by Whole-Genome Sequencing Directly From Clinical Specimens.
Hage E; Wilkie GS; Linnenweber-Held S; Dhingra A; Suárez NM; Schmidt JJ; Kay-Fedorov PC; Mischak-Weissinger E; Heim A; Schwarz A; Schulz TF; Davison AJ; Ganzenmueller T
J Infect Dis; 2017 Jun; 215(11):1673-1683. PubMed ID: 28368496
[TBL] [Abstract][Full Text] [Related]
3. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
[TBL] [Abstract][Full Text] [Related]
4. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome].
Roubalová K; Strunecký O; Zufanová S; Procházka B; Vitek A
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):92-9. PubMed ID: 20586171
[TBL] [Abstract][Full Text] [Related]
5. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
6. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
[TBL] [Abstract][Full Text] [Related]
7. Multiple-Strain Infections of Human Cytomegalovirus With High Genomic Diversity Are Common in Breast Milk From Human Immunodeficiency Virus-Infected Women in Zambia.
Suárez NM; Musonda KG; Escriva E; Njenga M; Agbueze A; Camiolo S; Davison AJ; Gompels UA
J Infect Dis; 2019 Jul; 220(5):792-801. PubMed ID: 31050737
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
[TBL] [Abstract][Full Text] [Related]
9. Bidirectional transfer of human cytomegalovirus strains in donor and recipient seropositive lung transplant patients.
Külekci B; Mollik M; Schwarz S; Perkmann-Nagele N; Geleff S; Jaksch P; Hoetzenecker K; Lambers C; Puchhammer-Stöckl E; Goerzer I
J Med Virol; 2024 Jul; 96(7):e29770. PubMed ID: 38949200
[TBL] [Abstract][Full Text] [Related]
10. Evolution of human cytomegalovirus-seronegative donor/-seropositive recipient high-risk combination frequency in allogeneic hematopoietic stem cell transplantations at Institute of Hematology and Blood Transfusion during 1995-2014.
Nemeckova S; Sroller V; Stastna-Markova M
Transpl Infect Dis; 2016 Apr; 18(2):297-301. PubMed ID: 26858009
[TBL] [Abstract][Full Text] [Related]
11. The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
Vinuesa V; Bracho MA; Albert E; Solano C; Torres-Puente M; Giménez E; González-Candelas F; Navarro D
J Gen Virol; 2017 Oct; 98(10):2530-2542. PubMed ID: 28874227
[TBL] [Abstract][Full Text] [Related]
12. Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status.
Servais S; Dumontier N; Biard L; Schnepf N; Resche-Rigon M; Peffault de Latour R; Scieux C; Robin M; Meunier M; Xhaard A; Sicre de Fontbrune F; Le Goff J; Socié G; Simon F; Mazeron MC
Clin Microbiol Infect; 2016 Mar; 22(3):289.e1-7. PubMed ID: 26627339
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation.
Dieamant DC; Bonon SH; Peres RM; Costa CR; Albuquerque DM; Miranda EC; Aranha FJ; Oliveira-Duarte G; Fernandes VC; De Souza CA; Costa SC; Vigorito AC
BMC Infect Dis; 2013 Jul; 13():310. PubMed ID: 23841715
[TBL] [Abstract][Full Text] [Related]
14. Analysis of human cytomegalovirus glycoprotein N genotypes in Chinese hematopoietic stem cell transplant recipients.
Xia CS; Zhang Z
Arch Virol; 2011 Jan; 156(1):17-23. PubMed ID: 20878191
[TBL] [Abstract][Full Text] [Related]
15. Impact of human cytomegalovirus infection UL55-nested polymerase chain reaction method in hematopoietic stem cell transplant donors and recipients.
Banan AA; Yaghobi R; Ramzi M; Mehrabani D
Transplant Proc; 2009 Sep; 41(7):2898-9. PubMed ID: 19765467
[TBL] [Abstract][Full Text] [Related]
16. ELISPOT assay of interferon-γ secretion for evaluating human cytomegalovirus reactivation risk in allo-HSCT recipients.
Liang H; Xia J; Zhang R; Yang B; Wu J; Gui G; Huang Y; Chen X; Yang R; Wang H; Gong S; Fan J
J Med Virol; 2021 Nov; 93(11):6301-6308. PubMed ID: 34076905
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation.
Baldanti F; Lilleri D; Gerna G
Hematol Oncol; 2008 Sep; 26(3):123-30. PubMed ID: 18386849
[TBL] [Abstract][Full Text] [Related]
18. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors Analysis for Human Cytomegalovirus Viremia in Donor+/Recipient+ Hematopoietic Stem Cell Transplantation.
Yang R; Zhang R; Zhang Y; Huang Y; Liang H; Gui G; Gong S; Wang H; Xu M; Fan J
Lab Med; 2020 Jan; 51(1):74-79. PubMed ID: 31150544
[TBL] [Abstract][Full Text] [Related]
20. Multiplex real-time PCR to identify a possible reinfection with different strains of human cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.
Zawilinska B; Szostek S; Kopec J; Piatkowska-Jakubas B; Kosz-Vnenchak M
Acta Biochim Pol; 2016; 63(1):161-166. PubMed ID: 26885773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
